You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Agarwal Arjun · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$273.32K
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 11, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 4 days later
ORKA daily price context
Close on/before transaction
$92.38
Sep 11, 2026
First close after public filing
$93.55
Sep 16, 2026
30-day return after filing
-21.04%
Through Oct 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,000 shares @ $91.11
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000097
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$1.08M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 15, 2026 | $53.6K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 11, 2026 | $205.92K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 11, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 11, 2026 | $100K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 11, 2026 | $50.18K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Sep 11, 2026 | $273.32K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 11, 2026 | $374.37K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 11, 2026 | $18.8K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 11, 2026 | $0 |